Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy

Published:2021-06 Issue: Volume:21 Page:329-339
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Zhang Shuyong,Zhou Dongdong,Zheng Chao,Xiong Peng,Zhu Wan,Zheng Dexian

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference38 articles.

1. Management of acute lymphoblastic leukemia in older patients;Larson;Semin. Hematol.,2006

2. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: From bench to bedside?;Izraeli;Br. J. Haematol.,2010

3. New immune strategies for the treatment of acute lymphoblastic leukemia: Antibodies and chimeric antigen receptors;Advani;Hematology (Am. Soc. Hematol. Educ. Program),2013

4. Genomics in acute lymphoblastic leukaemia: Insights and treatment implications;Roberts;Nat. Rev. Clin. Oncol.,2015

5. Acute lymphoblastic leukemia: A comprehensive review and 2017 update;Terwilliger;Blood Cancer J.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monomethyl Auristatin E (MMAE), a Payload for Multiple Antibody Drug Conjugates (ADCs), Demonstrates Differential Red Blood Cell Partitioning Across Human and Animal Species;Xenobiotica;2024-04-22

2. Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma;Cellular & Molecular Biology Letters;2024-04-10

3. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia;Cancer Letters;2024-04

4. Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis;International Journal of Biological Macromolecules;2024-01

5. Pharmacokinetics and toxicity considerations for antibody–drug conjugates: an overview;Bioanalysis;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3